|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of purchased intangible assets and other | |||||
| Restructuring charges | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest and other expense, net | |||||
| Gain from sale of a business | |||||
| Income before income taxes | |||||
| Income taxes | |||||
| Net income | |||||
| Net income attributable to noncontrolling interests | |||||
| Net Income (Loss) Attributable to Parent | |||||
| Basic earnings per ordinary share attributable to Amdocs Limited | |||||
| Diluted earnings per ordinary share attributable to Amdocs Limited |
Loading...
